Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2025-12-28 @ 4:11 AM
Study NCT ID:
NCT05861895
Status:
RECRUITING
Last Update Posted:
2024-08-01
First Post:
2023-04-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors
Sponsor:
HighField Biopharmaceuticals Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-22
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-20
First Submit QC Date:
None
Study First Post Date:
2023-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2024-08-01
Last Update Post Date Type:
ACTUAL